Hemab Therapeutics 控股 COAG
$49.02 +$3.45 (+7.57%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $49.02 0.00%
开盘$46.18
昨收$45.57
当日区间$45.52 – $49.12
成交量428.0K
市值$2.29B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$26.08M-62.4% YoY
净利润-$24.15M-97.8% YoY
摊薄每股收益-$0.80-79.8% YoY
自由现金流-$22.66M-47.8% YoY
经营现金流-$22.64M
营收，近4个季度
净利润，近4个季度
各季度摊薄每股收益
各季度自由现金流
盈利能力与资产负债表
净资产收益率-18.3%
资产收益率-17.8%
投入资本回报率-19.0%
流动比率35.85
负债/资产比率2.9%
现金及投资$457.46M
总负债$566,000.00
净现金（净负债）$456.89M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| 非经营性利息收入 | $2.86M | $1.22M | $1.97M | $335,000.00 | $473,000.00 |
| -管理费用 | $5.74M | $4.15M | $10.49M | $3.18M | $2.46M |
| 税前利润 | -$24.05M | -$22.68M | -$64.14M | -$12.21M | -$15.50M |
| 税费 | $97,000.00 | $12,000.00 | -$227,000.00 | $4,000.00 | -$190,000.00 |
| 净利润 | -$24.15M | -$22.69M | -$63.91M | -$12.21M | -$15.31M |
| 持续经营利润 | -$24.15M | -$22.69M | -$63.91M | -$12.21M | -$15.31M |
| 归属母公司净利润 | -$24.15M | -$22.69M | -$63.91M | -$12.21M | -$15.31M |
| 归属普通股股东净利润 | -$24.15M | -$22.69M | -$63.91M | -$12.21M | -$15.31M |
| 基本每股收益 | -$0.80 | -$0.51 | -$2.33 | -$0.44 | -$0.56 |
| 摊薄每股收益 | -$0.80 | -$0.51 | -$2.33 | -$0.44 | -$0.56 |
| 其他非经营性收入（支出） | -$832,000.00 | -$282,000.00 | $4.01M | $3.52M | $591,000.00 |
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $26.08M | $23.61M | $70.12M | $16.06M | $16.56M |
| 销售及管理费用 | $5.74M | $4.15M | $10.49M | $3.18M | $2.46M |
| 研发费用 | $20.34M | $19.46M | $59.63M | $12.87M | $14.10M |
| 营业利润 | -$26.08M | -$23.61M | -$70.12M | -$16.06M | -$16.56M |
| 非经营性利息净收入（支出） | $2.86M | $1.22M | $1.97M | $335,000.00 | $473,000.00 |
| 其他收入（支出） | -$832,000.00 | -$282,000.00 | $4.01M | $3.52M | $591,000.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2024 ANNUAL |
|---|---|---|---|---|
| -累计折旧 | -$871,000.00 | -$796,000.00 | -$723,000.00 | -$419,000.00 |
| 其他非流动资产 | $2.29M | $4.24M | $531,000.00 | $476,000.00 |
| 负债合计 | $13.51M | $373.88M | $371.42M | $211.55M |
| 流动负债合计 | $12.94M | $13.19M | $10.68M | $6.69M |
| 应付款 | $6.23M | $5.68M | $5.73M | $3.16M |
| -应付账款 | $6.23M | $5.68M | $5.73M | $3.16M |
| 一年内应计费用 | $3.74M | $5.68M | $1.29M | $1.19M |
| 短期债务及融资租赁负债 | $460,000.00 | $544,000.00 | $647,000.00 | $669,000.00 |
| -一年内到期融资租赁负债 | $460,000.00 | $544,000.00 | $647,000.00 | $669,000.00 |
| 非流动负债合计 | $566,000.00 | $360.69M | $360.74M | $204.87M |
| -固定资产原值 | $2.37M | $2.38M | $2.42M | $2.99M |
| 固定资产净值 | $1.50M | $1.59M | $1.70M | $2.57M |
| 总资产 | $467.78M | $175.26M | $194.78M | $96.28M |
| 流动资产合计 | $464.00M | $169.43M | $192.55M | $93.24M |
| 现金及现金等价物与短期投资 | $457.46M | $163.53M | $185.49M | $88.33M |
| -现金及现金等价物 | $237.37M | $49.86M | $87.97M | $74.41M |
| -短期投资 | $220.09M | $113.67M | $97.51M | $13.92M |
| 应收款 | $1.82M | $1.43M | $2.63M | $1.58M |
| -其他应收款 | $1.82M | $1.43M | $2.63M | $1.58M |
| 非流动资产合计 | $3.78M | $5.83M | $2.23M | $3.04M |
| 长期债务及融资租赁负债 | $566,000.00 | $519,000.00 | $573,000.00 | $1.06M |
| -长期融资租赁负债 | $566,000.00 | $519,000.00 | $573,000.00 | $1.06M |
| 可转换优先证券 | $0.00 | $360.17M | $360.17M | $203.75M |
| 资本公积 | $685.71M | $6.37M | $4.92M | $2.91M |
| 留存收益 | -$228.70M | -$204.55M | -$181.86M | -$117.95M |
| -优先股 | $0.00 | – | – | – |
| 股东权益合计 | $454.27M | -$198.62M | -$176.64M | -$115.27M |
| 股东权益 | $454.27M | -$198.62M | -$176.64M | -$115.27M |
| 股本 | $5,000.00 | $0.00 | $132,000.00 | $132,000.00 |
| -普通股 | $5,000.00 | $0.00 | $132,000.00 | $132,000.00 |
| 不影响留存收益的损益 | -$2.75M | -$439,000.00 | $175,000.00 | -$365,000.00 |
| 预付资产 | $4.72M | $4.47M | $4.44M | $3.33M |
| 其他非流动负债 | – | – | – | $63,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| 债务发行及偿还净额 | $0.00 | -$46,000.00 | -$120,000.00 | -$30,000.00 | -$29,000.00 |
| 持续经营筹资活动现金流净额 | $317.58M | -$460,000.00 | $156.30M | -$30,000.00 | -$29,000.00 |
| 投资购置及出售净额 | -$107.41M | -$15.74M | -$81.47M | $21.50M | -$5.98M |
| 固定资产购置及出售净额 | -$23,000.00 | -$112,000.00 | -$16,000.00 | $0.00 | -$16,000.00 |
| 持续经营投资活动现金流净额 | -$107.44M | -$15.85M | -$81.48M | $21.50M | -$5.99M |
| 投资活动现金流净额 | -$107.44M | -$15.85M | -$81.48M | $21.50M | -$5.99M |
| -其他流动负债变动 | -$159,000.00 | -$157,000.00 | -$522,000.00 | -$142,000.00 | -$156,000.00 |
| -其他流动资产变动 | -$739,000.00 | -$1.02M | -$55,000.00 | -$34,000.00 | -$800,000.00 |
| -应付账款及应计费用变动 | $2.12M | $382,000.00 | $4.09M | -$1.57M | $2.45M |
| -预付资产变动 | -$638,000.00 | $1.17M | -$2.16M | -$681,000.00 | -$65,000.00 |
| 期末现金余额 | $237.37M | $49.86M | $87.97M | $61.49M | $55.35M |
| 现金净变动 | $187.51M | -$37.89M | $13.34M | $6.14M | -$19.06M |
| 期初现金余额 | $49.86M | $87.97M | $74.41M | $55.35M | $74.41M |
| 筹资活动现金流 | $317.58M | -$460,000.00 | $156.30M | -$30,000.00 | -$29,000.00 |
| 自由现金流 | -$22.66M | -$21.70M | -$61.49M | -$15.33M | -$13.05M |
| 汇率变动影响 | $1,000.00 | -$223,000.00 | $223,000.00 | $0.00 | $0.00 |
| 营运资金变动 | $582,000.00 | $375,000.00 | $1.36M | -$2.42M | $1.43M |
| 其他非现金项目 | $160,000.00 | $153,000.00 | -$464,000.00 | -$1.15M | $521,000.00 |
| 经营活动现金流 | -$22.64M | -$21.58M | -$61.48M | -$15.33M | -$13.03M |
| 持续经营经营活动现金流净额 | -$22.64M | -$21.58M | -$61.48M | -$15.33M | -$13.03M |
| 持续经营净利润 | -$24.15M | -$22.69M | -$63.91M | -$12.21M | -$15.31M |
| 折旧、折耗与摊销 | $75,000.00 | $73,000.00 | $304,000.00 | $77,000.00 | $75,000.00 |
| 其他筹资费用净额 | – | -$414,000.00 | – | – | – |
| 优先股发行净额 | – | – | $156.42M | – | – |
暂无评论——快来第一个聊聊 COAG。
登录后参与讨论。